Role of Protein Kinase C in Endothelin Converting Enzyme-1 trafficking and shedding from endothelial cells

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 173-177

  Kuruppu, Sanjaya ^a   Tochon Danguy, Natalie ^a   Ian Smith, A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Ectodomain Shedding; Endothelin; Endothelin Converting Enzyme; Protein Kinase C and antibodies

Indexed keywords

AVIDIN; BIOTIN DERIVATIVE; BISINDOLYMALEIMIDE; CGS 35066; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENZYME ANTIBODY; MALEIMIDE DERIVATIVE; NEUTRAVIDIN BEAD; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; EXTRACELLULAR SPACE; FLUORESCENCE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN ISOLATION; WESTERN BLOTTING;

ASPARTIC ACID ENDOPEPTIDASES; BENZOFURANS; CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; METALLOENDOPEPTIDASES; PHOSPHONIC ACIDS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN TRANSPORT; TETRADECANOYLPHORBOL ACETATE;

EID: 77955056391     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.045     Document Type: Article

References (26)

1. Sakurai T., Goto K. Endothelins. Vascular actions and clinical implications. Drugs 1993, 46:795-804.
2. Ohnaka K., Takayanagi R., Nishikawa M., et al. Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. OFF. J. Biol. Chem. 1993, 268:26759-26766.
3. Hoang M.V., Turner A.J. Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin. Biochem. J. 1997, 327(Pt. 1):23-26.
4. Shimada K., Takahashi M., Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol. Chem. 1994, 269:18275-18278.
5. Schweizer A., Valdenaire O., Nelbock P., et al. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem. J. 1997, 328(Pt. 3):871-877.
6. MacLeod K.J., Husain R.D., Gage D.A., et al. Constitutive phosphorylation of human endothelin-converting enzyme-1 isoforms. J. Biol. Chem. 2002, 277:46355-46363.
7. Park M.J., Park I.C., Hur J.H., et al. Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci. Lett. 2000, 290:201-204.
8. Amadio M., Scapagnini G., Lupo G., et al. PKCbetaII/HuR/VEGF: a new molecular cascade in retinal pericytes for the regulation of VEGF gene expression. Pharmacol. Res. 2008, 57:60-66.
9. Rotmann A., Strand D., Martine U., et al. Protein kinase C activation promotes the internalization of the human cationic amino acid transporter hCAT-1. A new regulatory mechanism for hCAT-1 activity. J. Biol. Chem. 2004, 279:54185-54192.
10. Rotmann A., Vekony N., Gassner D., et al. Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane. Biochem. J. 2006, 395:117-123.
11. Slater S.J., Kelly M.B., Taddeo F.J., et al. Evidence for discrete diacylglycerol and phorbol ester activator sites on protein kinase C. Differences in effects of 1-alkanol inhibition, activation by phosphatidylethanolamine and calcium chelation. J. Biol. Chem. 1994, 269:17160-17165.
12. Dello Sbarba P., Rovida E. Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol. Chem. 2002, 383:69-83.
13. Lambert D.W., Yarski M., Warner F.J., et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 2005, 280:30113-30119.
14. Heaney M.L., Golde D.W. Soluble receptors in human disease. J. Leukoc. Biol. 1998, 64:135-146.
15. Smith A.I., Lew R.A., Thomas W.G., et al. Protein kinase C regulates the cell surface activity of endothelin-converting enzyme-1. Int. J. Pept. Res. Ther. 2006, 12:291-295.
16. Kuruppu S., Reeve S., Ian Smith A. Characterisation of endothelin converting enzyme-1 shedding from endothelial cells. FEBS Lett. 2007, 581:4501-4506.
17. Cooper H., Paterson Y. Current Protocols in Molecular Biology 1997, John Wiley and Sons Inc., New York.
18. Norman M.U., Reeve S.B., Dive V., et al. Endopeptidases 3.4.24.15 and 24.16 in endothelial cells: potential role in vasoactive peptide metabolism. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1978-H1984.
19. Ahn K., Pan S., Beningo K., et al. A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells. Life Sci. 1995, 56:2331-2341.
20. Bremnes T., Paasche J.D., Mehlum A., et al. Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 2000, 275:17596-17604.
21. Tsien R.Y. The green fluorescent protein. Annu. Rev. Biochem. 1998, 67:509-544.
22. Arribas J., Massague J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J. Cell Biol. 1995, 128:433-441.
23. Hwang C., Gatanaga M., Granger G.A., et al. Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J. Immunol. 1993, 151:5631-5638.
24. Anstadt M.P., Hutchinson J., Portik-Dobos V., et al. Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes. Ethn. Dis. 2002, 12:S3-5-9.
25. Rayhman O., Klipper E., Muller L., et al. Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells. Cancer Res. 2008, 68:9265-9273.
26. Martinez-Miguel P., Raoch V., Zaragoza C., et al. Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins. J. Lipid Res. 2009, 50:364-375.